Increased thrombophilic tendency in pediatric cystic fibrosis patients

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 1, 2010, Pages 71-76

  Williams, Vaughan ^a   Griffiths, Adrian B M ^a   Yap, Zen L ^a   Martin, James ^b   Smith, Gregory ^b   Couper, Richard ^a   Revesz, Tamas ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Activated protein C resistance; Cystic fibrosis; Lupus anticoagulant; Protein C; Protein S; Thrombophilia

Indexed keywords

ANTITHROMBIN; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; INCIDENCE; INDWELLING CATHETER; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; THROMBOPHILIA;

ADOLESCENT; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INCIDENCE; INFANT; LUPUS COAGULATION INHIBITOR; MALE; PROTEIN C; PROTEIN S; THROMBOPHILIA; YOUNG ADULT;

EID: 76049106910     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609334627     Document Type: Article

References (22)

1. Deerojanawong J., Sawyer SM, Fink AM, Stokes KB, Roberston CF Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Thorax. 1998 ; 53 (4). 285-289.
2. Van Koningsbruggen S., Hamm M., Geisen C., Michalk D., Rietschel E. Protein C, protein S, antithrombin III, and APC resistance in CF patients. Pediatr Pulmonol Suppl. 2000 ; 20: 345 [abstract].
3. Stone A., Goodell W., Aljadeff G., et al. Hypercoagulable states and CVL related thrombi in the cystic fibrosis population. Pediatr Pulmonol Suppl. 2003 ; 25: 324 [abstract].
4. Balfour-Lynn IM, Malbon K., Burman JF, Davidson SJ Thrombophilia in children with cystic fibrosis. Pediatr Pulmonol. 2005 ; 39 (4). 306-310.
5. Barker M., Thoenes D., DÅhmen H., Friedrichs F., Pfannenstiel C., Heimann G. Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis. Pediatr Pulmonol. 2005 ; 39 (2). 156-161.
6. Andrew M., Vegh P., Johnston M., Bowker J., Ofosu F., Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992 ; 80 (8). 1998-2005.
7. Monagle P., Barnes C., Ignjatovic V., et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006 ; 95 (2). 362-372.
8. Shi W., Krilis SA, Chong BH, Gordon S., Chesterman CN Prevalence of lupus anticoagulant and anticardiolipin antibodies in healthy population. Aust NZ J Med. 1990 ; 20 (3). 231-236.
9. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 1995 ; 73 (1). 87-93.
10. Dykes AC, Walker ID, McMahon AD, Islam Siam, Tait RC A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol. 2001 ; 113 (3). 636-641.
11. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994 ; 87 (1). 106-112.
12. Rees DC, Cox M., Clegg JB World distribution of factor V Leiden. Lancet. 1995 ; 346 (8983). 1133-1134.
13. Male C. Lechner K., Eichinger S., et al. Clinical significance of lupus anticoagulants in children. J Pediatr. 1999 ; 134 (2). 199-205.
14. Male C., Lechner K., Speiser W., Pabinger I. Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features. Thromb Haemost. 2000 ; 83 (1). 174-175.
15. Playfor SD, Smyth AR Paradoxical embolism in a boy with cystic fibrosis and a stroke. Thorax. 1999 ; 54 (12). 1139-1140.
16. Espiritu JD, Kleinhenz ME Paradoxical embolization in an adult patient with cystic fibrosis. Mayo Clin Proc. 2000 ; 75 (10). 1100-1102.
17. Male C., Mitchell L., Julian J., et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood. 2001 ; 97 (4). 844-849.
18. Kurugol Z., Vardar F., Ozkinay F., Kavakli K., Ozkinay C. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paed. 2000 ; 89 (10). 1186-1189.
19. Joyce DE, Nelson DR, Grinnell BW, Brian W. Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med. 2004 ; 32 (5 Suppl). S280 - S286.
20. Nick JA, Coldren CD, Geraci MW, et al. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood. 2004 ; 104 (13). 3878-3885.
21. Rigby AC, Grant MA Protein S: a conduit between anticoagulation and inflammation. Crit Care Med. 2004 ; 32 (5 Suppl). S336 - S341.
22. Rezende SM, Simmonds RE, Lane DA Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood. 2004 ; 103 (4). 1192-1201.